Safety and Tolerability of Artificial Tears in Dry Eye Subjects
Study Identifier
AG9965-001
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.
Study Locations
Location
Status
Location
San Diego, California, United States
Status
Not applicable